• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Revolutions Medical Chooses SON Medical to Facilitate Lab Testing for FDA 510k Application

Posted on: Monday, 5 March 2007, 12:01 CST

Revolutions Medical Corporation, (OTC: RMCP) Mount Pleasant, SC, announces its choice for FDA lab testing for its 3cc safety syringe (Rev Vac). SON Medical is a vertically integrated contract regulatory and testing consulting firm located in the Boston area. Their personnel have been providing excellent service to the medical industry for over 15 years. With their in-house capabilities they will assist Rev Med with product testing validation, risk management, quality assurance and regulatory approval for our Rev Vac 3cc safety syringe.

Rich Theriault, President of Strategic Product Development (SPD), states "This is a key component in providing a high quality cost effective resource for testing and validation in preparation for FDA submission. Their experience will assist us greatly in our goal of a rapid and trouble free submittal and approval."

According to Dave Rothkopf, Chief of regulatory affairs for SPD, "SON Medical brings an in depth suite of testing capabilities and regulatory knowledge to meet our quality needs. Their independent testing services will provide expert validation and feedback for the regulatory submissions."

"Rev Med continues to move forward through the development and regulatory process to bring its Rev Vac safety syringe to the market, states Ron Wheet, CEO of Revolutions Medical Corporation. Furthermore, we are now seeking and evaluating manufacturing and distribution strategic partners with the assistance of our new consulting relationships."

Revolutions Medical Corporation commenced a lawsuit on March 1, 2007. The lawsuit was filed in the District Court of Tulsa County, Oklahoma against Globe Med Tech, Inc., to rescind, terminate and seek monetary damages for the non-fulfillment and breach of a joint venture agreement entered into November 3, 2005 and other related agreements, in addition to an accounting of expenditures of funds under the terms and provisions of the agreements.

About Revolutions Medical Corporation

Revolutions Medical Corporation is committed to continually developing and distributing new products and tools to the medical industry, whether internally or through acquisitions. Its goals are to make health care safer and less expensive by reducing risks and cutting time and expenses. Its products include the Rev Vac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion.

Safe Harbor

Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward- looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.

Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.

Source: Business Wire

More News in this Category